Pharmacovigilance is the science and set of activities aimed at the detection, assessment, understanding, and prevention of adverse events or any other problems related to medicinal products, involving physicians, the pharmaceutical industry, and patients. Through Pharmacovigilance, we conduct safety monitoring of all medicines throughout their development, life cycle, and commercialization stage. Any medicinal product may cause an adverse event, even those with extensive development, research, or marketing histories that comply with rigorous quality standards.
Pharmacovigilance is the responsibility of the prescribing physician, the pharmaceutical industry, health authorities, and patients.
What are the objectives of Pharmacovigilance?
- To improve patient care and safety.
- To improve public health in relation to the use of medicines.
- To detect problems related to the use of medicines.
- To promote the safe, rational, and more effective use of medicines.
Adverse Effects
An adverse effect is defined as any medical condition or undesirable event that occurs in a patient after receiving, or while receiving, a medicinal product. An adverse event may therefore be any unfavorable and unintended sign or symptom that is temporally associated with the use of a medicinal product, whether or not it is related to the product. At Laboratorios CASASCO S.A.I.C., we are committed to providing the highest standards of quality and maximum safety in order to ensure the expected outcomes and benefits of our products. To this end, we carry out continuous monitoring throughout the development and commercialization stages, in collaboration with healthcare professionals.
We invite you to contact us and report any medical event associated with the use of our products.